![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 17, 18063-18072, April 23, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
M
2 Orchestrates and Accelerates Plasminogen Activation and Fibrinolysis by Neutrophils*




¶
From the
Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Department of Molecular Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195 and the
Department of Pathology and Laboratory Medicine, University of Pennsylvania Hospitals, Philadelphia, Pennsylvania 19104
Plasmin, the pivotal thrombolytic enzyme, is generated on the surface of many cell types, where urokinase receptor (uPAR)-bound urokinase (uPA) activates cell-bound plasminogen (Plg). It has been reported that neutrophils mediate endogenous thrombolysis involving a uPA-dependent mechanism, and we previously demonstrated that both uPAR and integrin
M
2 recognize uPA to control cell migration and adhesion. In the present study, we report that the
M
2 regulates neutrophil-dependent fibrinolysis. Phorbol 12-myristate 13-acetate (PMA)-stimulated but not resting neutrophils dissolved fibrin clots, and this activity was not only uPA- and Plg-dependent but also
M
2-dependent. Purified
M
2 directly bound uPA (Kd = 40 nM) and Plg (Kd = 1 µM) in a dose-dependent and saturable manner. In Plg activation assays, addition of purified
M
2, but not a control protein, to a single chain uPA (sc-uPA)/Plg mixture, decreased the Km from 2 to 0.1 µM, thereby augmenting the overall reaction efficiency by 50-fold. The binding of sc-uPA to
M
2 was critical for the
M
2-mediated enhancement of plasmin (Plm) generation, because this effect was lost when WT-sc-uPA was replaced with a kringle-less mutant (
K-sc-uPA), which does not bind to
M
2. Plm inactivation by
2-antiplasmin was significantly delayed when Plm was preincubated with purified, soluble
M
2. When Plg was added to PMA-stimulated neutrophils, both uPA and Plg were co-immunoprecipitated with
M
2. Thus, assembly of Plg and uPA on integrin
M
2 regulates Plm activity and, thereby, plays a crucial role in neutrophil-mediated thrombolysis.
Received for publication, September 22, 2003 , and in revised form, February 3, 2004.
* This work was supported in part by National Institutes of Health Grants HL66197, HL17964, and HL60169 and American Heart Association Scientist Development Grant 0335088N (to E. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Molecular Cardiology, Joseph J. Jacobs Center for Thrombosis and Vascular Biology, NB50, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-445-8201; Fax: 216-445-8204; E-mail: plowe{at}ccf.org.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Das, T. Burke, and E. F. Plow Histone H2B as a functionally important plasminogen receptor on macrophages Blood, November 15, 2007; 110(10): 3763 - 3772. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ganguly, J.-C. Murciano, R. Westrick, J. Leferovich, D. B. Cines, and V. R. Muzykantov The Glycocalyx Protects Erythrocyte-Bound Tissue-Type Plasminogen Activator from Enzymatic Inhibition J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 158 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Soloviev, W. A. Fonzi, R. Sentandreu, E. Pluskota, C. B. Forsyth, S. Yadav, and E. F. Plow Identification of pH-Regulated Antigen 1 Released from Candida albicans as the Major Ligand for Leukocyte Integrin {alpha}Mbeta2 J. Immunol., February 15, 2007; 178(4): 2038 - 2046. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Brooks, M. E. Bates, R. F. Vrtis, N. N. Jarjour, P. J. Bertics, and J. B. Sedgwick Urokinase-Type Plasminogen Activator Modulates Airway Eosinophil Adhesion in Asthma Am. J. Respir. Cell Mol. Biol., October 1, 2006; 35(4): 503 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kwon, C.-S. Yoon, W. Jeong, S. G. Rhee, and D. M. Waisman Annexin A2-S100A10 Heterotetramer, a Novel Substrate of Thioredoxin J. Biol. Chem., June 24, 2005; 280(25): 23584 - 23592. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Gyetko, D. Aizenberg, and L. Mayo-Bond Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro J. Leukoc. Biol., September 1, 2004; 76(3): 648 - 656. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |